NEWS STORIES

HHS Allots Additional $162 Million to Advance Widespread Meaningful Use of Health IT
US Department of Health and Human Services Secretary Kathleen Sebelius today announced awards to help states facilitate health information exchange and advance health information technology (health IT).
3/17/2010

Research and Markets Adds Report on US Companion Diagnostics Market
Research and Markets has announced the addition of Frost & Sullivan's new report "U.S. Companion Diagnostics Markets" to their offering.
3/16/2010

Is Prenatal Screening for Rare Diseases Too Costly?
Spinal Muscular Atrophy (SMA) is one of many serious disorders for which prenatal testing is available. SMA affects approximately 1 in 10,000 live births and is the leading genetic cause of infant mortality and the second most common autosomal recessive disorder, after cystic fibrosis.
3/17/2010

Enzo Biochem, MultiGEN Diagnostics Sign DNA Sequencing Marketing Agreement
Enzo Biochem announced that it has entered into an agreement with MultiGEN Diagnostics Inc, of San Diego for exclusive rights to market MultiGENs unique diagnostic tests based on multiplex DNA sequencing, in the state of New York.
3/16/2010

Roche Purchases Microarray Instrument from BioMicro Systems
Roche Diagnostics has purchased assets from BioMicro Systems for all products associated with the Roche NimbleGen microarray workflow.
3/12/2010

BioImagene Introduces the iSlide for Transitioning to Digital Pathology
BioImagene Inc announced the availability of the iSlide input device, an innovative device that allows pathologists to use a microscope-like interface to manipulate digital images of slides..
3/16/2010

In Cancer Diagnostics, the Profit Is in Test Services
The majority of new cancer tests coming to market are proprietary assays with the test services being provided by certified labs opened by the IVD companies that developed the test. This shift is leading to greater profits for those companies offering test services, notes health care market research publisher Kalorama Information.
3/15/2010

Biosearch Technologies Expands Licensing of Roche Patents
Biosearch Technologies Inc announced that the company has expanded its licenses from Roche Molecular Systems. The expanded license grants Biosearch the right to manufacture and sell validated kits to the in-vitro diagnostic (IVD) marketplace as licensed products covered by multiple patents assigned to Roche.
3/11/2010

PRESS RELEASES

Unedited news and product information from vendors.

'Reform Your Own Health' During National Kidney Month

Ambry Genetics and RainDance Technologies Announce Partnership for Diagnostics and Genomics Services Utilizing the RDT 1000 for Sequence Enrichment and Targeted Resequencing Validation

GenVault Provides GenTegra(TM) DNA to Support Cardiovascular Genetic Testing at Berkeley HeartLab

Prometheus and Bayer Schering Pharma to Apply Novel Diagnostic Platform to Oncology Therapeutic Candidates

MEDIA CENTER

Interactive Media
Resources
Calendar
Consumer Resources
Media Kit
Advertiser Index
EAB
Reprints

Special Section

Respiratory Viruses

Sponsored by:



Stimulus 2009: What the American Recovery and Reinvestment Act Means for Clinical Labs


Sponsored by:
Olympus AmericaThermo Scientific


Copyright © 2010 Allied Media, a division of Anthem Media Group | Clinical Lab Products | All Rights Reserved.
Privacy Policy | Terms of Service